Cefdinir Thiazine Analog
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

178422-39-4Cefdinir Thiazine Analog

● In Stock

Catalogue No.:VE0010021
CAS No.:178422-39-4
Mol. Formula:C14H15N5O6S2
Mol. Weight:413.43 g/mol

Additional information on CAS 178422-39-4

Parent drug

Cefdinir

IUPAC Name

[R-[R*,R*-(Z,Z)]]-α-[[(2-Amino-4-thiazolyl)(hydroxyimino)acetyl]amino]-4-carboxy-5-ethylidene-5,6-dihydro-2H-1,3-thiazine-2-acetic acid

Synonyms

N/A

Description

Cefdinir Thiazine Analog, CAS 178422-39-4, is a process-related heterocyclic impurity associated with cefdinir chemistry, plausibly arising from cyclization, sulfur oxidation state rearrangement, or other late-stage synthetic divergence within the cephalosporin framework. With molecular formula C14H15N5O6S2 and molecular weight 413.43 g/mol, it retains the beta-lactam derived heteroatom pattern yet differs in ring topology and substitution, which can alter chromatographic behavior and UV response. Characterization typically requires LC-MS/MS, high-resolution LC-MS, and orthogonal LC-UV methods, with impurity profiling guided by ICH impurity and mutagenic risk assessment principles when structural alerts are evaluated.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url